Shenling Baizhu granules (TCM patent medicine)
KY2024-191-C
Approved small_molecule active
Quick answer
Shenling Baizhu granules (TCM patent medicine) for Low-risk Colorectal Adenoma is a Approved program (small_molecule) at INTEGRATED BIOPHARMA INC with 1 ClinicalTrials.gov record(s).
Program details
- Company
- INTEGRATED BIOPHARMA INC
- Indication
- Low-risk Colorectal Adenoma
- Phase
- Approved
- Modality
- small_molecule
- Status
- active